Outcomes of Left-Lobe Donor Hepatectomy for Living-Donor Liver Transplantation: A Single-Center Experience

dc.authoridAtes, Mustafa/0000-0003-2821-453X
dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authoridIsik, Burak/0000-0002-2395-3985
dc.authorwosidAtes, Mustafa/ABI-5100-2020
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.authorwosidIsik, Burak/A-6657-2018
dc.contributor.authorUsta, S.
dc.contributor.authorAtes, M.
dc.contributor.authorDirican, A.
dc.contributor.authorIsik, B.
dc.contributor.authorYilmaz, S.
dc.date.accessioned2024-08-04T20:37:33Z
dc.date.available2024-08-04T20:37:33Z
dc.date.issued2013
dc.departmentİnönü Üniversitesien_US
dc.description9th Congress of the Turkish-Transplantation-Centers-Coordination-Association (TTCCA) -- SEP 26-29, 2012 -- Bursa, TURKEYen_US
dc.description.abstractLiving-donor liver transplantation (LDLT) is an excellent option for patients with end-stage liver disease in situations of donor shortage. The aims of this study were to evaluate our experience with left-lobe donor hepatectomy for LDLT and to grade postoperative complications using the 5-tier Clavien classification system. Data from medical records of 60 adult living liver donors (30 men, 30 women) who underwent left-lobe hepatectomy between November 2006 and April 2012 were reviewed. The median donor age was 31.7 +/- 8.9 (range, 19-63) years. Sixteen complications were observed in 12/60 (20%) donors. Complications developed in 6/15 (40%) donors who underwent left hepatectomy and in 6/45 (13.3%) donors who underwent left lateral segmentectomy. Seven of 16 (43.7%) complications were Grade I and 2 (12.5%) were Grade II. Major complications consisted of 4 (25%) Grade IIIa and 3 (18.7%) Grade IIIb complications; no Grade IVb or V complications occurred. The most common complication was biliary, occurring in 7 (11.6%) donors and comprising 43.7% of all 16 complications. The mean duration of follow-up was 30 +/- 7.1 (range, 2-58) months. No donor mortality occurred. Left-lobe donor hepatectomy for LDLT, which does not benefit the completely healthy donor, was performed safely and with low complication rates, but carries the risk of morbidity. Low morbidity rates following living-donor hepatectomy can be expected when surgical and clinical monitoring and follow-up are adequate and the surgeon has gained increased experience.en_US
dc.description.sponsorshipTurkish Transplantat Ctr Coordinat Assoc (TTCCA)en_US
dc.identifier.doi10.1016/j.transproceed.2013.02.065
dc.identifier.endpage965en_US
dc.identifier.issn0041-1345
dc.identifier.issn1873-2623
dc.identifier.issue3en_US
dc.identifier.pmid23622599en_US
dc.identifier.scopus2-s2.0-84876839837en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage961en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2013.02.065
dc.identifier.urihttps://hdl.handle.net/11616/96034
dc.identifier.volume45en_US
dc.identifier.wosWOS:000318457000031en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectComplicationsen_US
dc.titleOutcomes of Left-Lobe Donor Hepatectomy for Living-Donor Liver Transplantation: A Single-Center Experienceen_US
dc.typeConference Objecten_US

Dosyalar